Brief: Lilly Extends Tender Offer To Acquire Point Biopharma To December 1, 2023
Nov 17 (Reuters) - Eli Lilly and Co LLY.N :
* LILLY EXTENDS TENDER OFFER TO ACQUIRE POINT BIOPHARMA TO
DEC. 1,
2023
* ELI LILLY - TENDER OFFER HAS BEEN EXTENDED UNTIL 5:00
P.M.,
EASTERN TIME, ON DEC. 1, 2023
* ELI LILLY - ALL REGULATORY APPROVALS NECESSARY FOR
CONSUMMATION
OF TRANSACTION HAVE BEEN OBTAINED
Source text for Eikon: ID:nPn6tMM13a
Further company coverage: LLY.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on POINT Biopharma Global
See all newsBrief: Eli Lilly Completes Acquisition Of POINT Biopharma
Fusion Pharma gains on Bristol Myers-RayzeBio deal
Brief: Point Biopharma- Lilly Offer Expired And Not Further Extended - SEC Filing
Brief: BVF Partners Dissolves Share Stake In Point Biopharma Global
U.S. STOCKS ON THE MOVE-Biomerica, Netflix, SunPower